View Older Stories View More Recent Stories

Jun 6, 2025 07:02AM EMA says Ozempic, Wegovy may cause rare eye condition
May 22, 2025 02:52PM Citi Drops Third Note on Hims and Hers (HIMS) Inside 20 Hours: 'HIMS is now offering discounts on its bundles, effectively passing through the price discount'
May 22, 2025 09:49AM Hims & Hers Health: Analysts remain bearish
May 22, 2025 08:06AM LifeMD, Inc. (LFMD) Collaborates with Novo Nordisk to Launch $299 Introductory Bundle for Self-Pay Patients Prescribed Wegovy
May 22, 2025 08:04AM New Novo Nordisk (NVO) initiatives support patient access to authentic, FDA-approved Wegovy® as federal ban on mass compounding of "semaglutide" takes effect
May 21, 2025 07:36AM Takeaways from UBS's 2025 Healthcare Insurance Symposium
May 19, 2025 08:32AM BMO Capital on Novo Nordisk (NVO): 'CEO Switch Up Highlights Recent Novo Pressures'
May 16, 2025 07:04AM Novo Nordisk (NVO): Lars Fruergaard Jørgensen to step down as CEO of Novo Nordisk
May 14, 2025 08:22AM BMO Capital Reiterates Market Perform Rating on Novo Nordisk (NVO)
May 14, 2025 07:03AM Septerna (SEPN) and Novo Nordisk (NVO) to collaborate on oral small molecule medicines for obesity and other cardiometabolic diseases
May 12, 2025 10:11AM Trump discusses price gouging of 'fat drugs' in the U.S.
May 7, 2025 04:32PM Trump to pitch sweeping Medicare drug price plan - Politico
May 7, 2025 09:58AM Novo Nordisk (NOVOB:DC) (NVO) PT Lowered to DKK850 at BofA Securities
May 7, 2025 03:54AM Novo Nordisk (NVO) Reports Q1 EPS of DKK6.53
May 6, 2025 11:30PM Novo Nordisk earnings preview: Q1 miss, guidance cut in focus as obesity drug demand cools
May 6, 2025 10:20AM Novo Nordisk (NVO) call put ratio 1.3 calls to 1 put into quarter results
May 6, 2025 05:59AM Novo Nordisk (NVO) May 9 weekly straddle priced into quarter results
May 2, 2025 03:33PM Novo Nordisk shares jump as FDA accepts oral Wegovy application
May 2, 2025 02:40PM FDA accepts filing application for Novo Nordisk's (NVO) Wegovy oral form
Apr 29, 2025 08:41AM Hims & Hers shares surge over 40% on Wegovy pact with Novo Nordisk
Apr 29, 2025 07:59AM Hims & Hers Health, Inc. (HIMS) Short Sellers Pressured as Shares Spike Following Novo Nordisk (NVO) Pact
Apr 29, 2025 07:31AM Hims & Hers Health, Inc. (HIMS) and Novo Nordisk Team Up to Expand Affordable Access to Care
Apr 17, 2025 05:11AM BMO Capital Downgrades Novo Nordisk (NVO) to Market Perform
Apr 16, 2025 10:16AM BNP Paribas Exane Starts Novo Nordisk (NOVOB:DC) (NVO) at Underperform
Apr 9, 2025 09:19AM Pharma stocks slide after Trump signals tariffs on sector
Apr 7, 2025 10:56AM Novo Nordisk (NVO) to invest 6.4B Reais to increase factory capacity in Brazil - CEO
Apr 4, 2025 04:23PM Trump Admin Drops Biden Medicare Obesity Drug Coverage Proposal - Bloomberg
Mar 28, 2025 07:30AM Lexicon Pharma (LXRX) Announces Exclusive License Agreement with Novo Nordisk for LX9851
Mar 28, 2025 06:22AM Novo Nordisk (NVO) call put ratio 1 call to 2.2 puts amid wide price movement
Mar 27, 2025 06:00PM 2 reasons why Novo Nordisk shares may underperform in near term: analyst
Mar 26, 2025 06:00PM Weighing in on obesity: Catalyst-rich 2025 ahead in a growing competitive landscape
Mar 26, 2025 09:45AM Truist Weighs In on Obesity: 'Catalyst-Rich 2025 Ahead in a Growing Competitive Landscape'
Mar 25, 2025 04:00PM FINAL REMINDER NVO DEADLINE: Bronstein, Gewirtz & Grossman LLC Alerts Novo Nordisk A/S Investors to Participate in the Class Action Lawsuit!
Mar 25, 2025 12:23PM NVO DEADLINE TODAY: ROSEN, LEADING INVESTOR COUNSEL, Encourages Novo Nordisk A/S Investors to Secure Counsel Before Important March 25 Deadline in Securities Class Action - NVO
Mar 25, 2025 10:48AM INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Novo Nordisk
Mar 25, 2025 09:06AM BMO Capital Reiterates Outperform Rating on Novo Nordisk (NVO)
Mar 24, 2025 04:00PM FINAL REMINDER NVO DEADLINE: Bronstein, Gewirtz & Grossman LLC Alerts Novo Nordisk A/S Investors to Participate in the Class Action Lawsuit!
Mar 24, 2025 12:18PM NVO DEADLINE TOMORROW: ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Novo Nordisk A/S Investors to Secure Counsel Before Important March 25 Deadline in Securities Class Action - NVO
Mar 24, 2025 08:04AM Novo Nordisk (NVO) expands Wegovy $499-per-month offering to additional cash-paying patients via the Wegovy savings offer
Mar 21, 2025 11:11PM NVO DEADLINE NOTICE: ROSEN, A LEADING LAW FIRM, Encourages Novo Nordisk A/S Investors to Secure Counsel Before Important March 25 Deadline in Securities Class Action - NVO
Mar 21, 2025 02:48PM NVO DEADLINE ALERT: Novo Nordisk (NVO) Investors with Losses Encouraged to Contact Hagens Berman Before Mar. 25th Deadline in Securities Class Action
Mar 20, 2025 11:06PM NVO DEADLINE ALERT: ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Novo Nordisk A/S Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action - NVO
Mar 19, 2025 11:01PM NVO DEADLINE ALERT: ROSEN, NATIONAL INVESTOR COUNSEL, Encourages Novo Nordisk A/S Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action - NVO
Mar 18, 2025 08:23PM ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Novo Nordisk A/S Investors to Secure Counsel Before Important Deadline in Securities Class Action - NVO
Mar 17, 2025 08:18PM ROSEN, HIGHLY RECOGNIZED INVESTOR COUNSEL, Encourages Novo Nordisk A/S Investors to Secure Counsel Before Important Deadline in Securities Class Action - NVO
Mar 17, 2025 02:19PM INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Novo Nordisk
Mar 17, 2025 12:35PM NVO DEADLINE ALERT: Novo Nordisk (NVO) Investors with Losses Encouraged to Contact Hagens Berman Before Mar. 25th Deadline in Securities Class Action
Mar 16, 2025 06:41PM ROSEN, LEADING INVESTOR COUNSEL, Encourages Novo Nordisk A/S Investors to Secure Counsel Before Important Deadline in Securities Class Action - NVO
Mar 15, 2025 06:41PM ROSEN, A TOP RANKED LAW FIRM, Encourages Novo Nordisk A/S Investors to Secure Counsel Before Important Deadline in Securities Class Action - NVO
Mar 14, 2025 06:36PM ROSEN, LEADING INVESTOR COUNSEL, Encourages Novo Nordisk A/S Investors to Secure Counsel Before Important Deadline in Securities Class Action - NVO
View More Recent Stories View Older Stories